Genetic therapy for pancreatic neoplasms

World Chinese Journal of Digestology

Volumn 8, Issue 8, 2000, Pages 916-918

  Leng, J J ^a   Chen, Y Q ^a   Leng, X S ^a  

^a NONE

Author keywords

Cystosine deaminase; Gene therapy; Genes suppressor, tumor; Genes, p53; Herpes simplex virus thymidine kinase; Hormones therapeutic use; Pancreatic neoplasms therapy

Indexed keywords

GANCICLOVIR; PROTEIN P53; THYMIDINE KINASE; VIRUS VECTOR;

CANCER GENETICS; GENE THERAPY; HERPES SIMPLEX VIRUS; PANCREAS TUMOR; SHORT SURVEY;

EID: 0033840692     PISSN: 10093079     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (20)

1. Clinical significance of serum p53 antigen in patients with pancreatic carcinomas
2. Adenovirus-mediated wild-type p53 tumor suppressor gene therapy induces apoptosis and suppresses growth of human pancreatic cancer
3. Gene therapy for primary and metastatic pancreatic cancer with intraperitoneal retroviral vector bearing the Wild-Type p53 gene
4. Suppression of pancreatic cancer by the dominant negative ras mutant, N116Y
5. Gene therapy of metastatic pancreas cancer with intraperitoneal injections of concentrated retroviral herpes simplex thymidine kinase vector supernatant and ganciclovir
6. Enhanced pancreatic tumor regression by a combination of adenovirus and retrovirus-mediated delivery of the herpes simplex virus thymidine kinase gene
7. Direct gene transfer into the rat pancreas using DNA-liposomes
8. Gene therapy for peritoneal dissemination of pancreatic cancer by liposome-mediated transfer of herpes simplex virus thymidine kinase gane
9. The 'bystander effect': Tumor regression when a fraction of the tumor mass is genetically modified
10. In vivo adenovirus-mediated prodrug gene therapy for carcinoembryonic antigen-producing pancreatic cancer
11. Intercellular communication mediates the bystander effect during herpes simplex thymidine kinase/ganciclovir-based gene therapy of human gastrointestinal tumor cells
12. In vivo adenoviral-mediated gene transfer in the treatment of pancreatic cancer
13. An apoptosis-inducing gene therapy for pancreatic cancer with a combination of 55-kDa tumor necrosis factor (TNF) receptor gene transfection and mutein TNF administration
14. Gene therapy for pancreatic carcinoma: Local and distant antitumor effects after somatostatin receptor SST2 gene transfer
15. Estrogen receptors in 7, 12- dimethylbenz (a) anthracene (DMBA) induced pancreatic carcinoma in rats and in human pancreatic carcinoma
16. Expression of Fas-estrogan receptor fusion protein induces cell death in pancreatic cancer cell lines